sglt2 inhibitors and glp 1 agonist Criteria for recommendation of or GLP-1 receptor Benefits of treatment with SGLT2i

WEIGHT-LOSS DRUGS NOW LINKED TO CANCER PROTECTION IN WOMEN, MAJOR NEW STUDY REVEALS According to a press release, the real-world retrospective study included 12,112 patients with the following types of obesity-related cancers, ranging from stage 1 to stage 3

Heerspink HJ, Sattar N, Pavo I, Haupt A, Duffin KL, Yang Z, et al

In several RCTs, GLP-1 receptor agonists were compared with insulin or insulin-based intensification strategies, therapies that have been associated with hyperinsulinemia and potential pro-proliferative signaling

For patients, this means that some copycat versions of these drugs, which were allowed to be sold from telehealth providers during the shortage, will soon be restricted, leaving these patients looking for alternative prescriptions

Age, AUDIT-C score, body mass index (BMI), and sex were also included in the models